Cigna (CI) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.
Past insider buys here: 1 of 1 beat the S&P 500 over the next 90 days (small sample). See each one ↓
Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.- Next earnings expected around Feb 11, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Sale Everett Neville, See Remarks sold 617 shares at $284.05 ($175K).
- Trade date
- Sep 3, 2026
- Disclosed to the SEC
- Sep 8, 2026
- Type
- Pre-planned sale, 10b5-1 (code S)
Read the original SEC filing ↗All CI insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
CI insider transactions (Form 4)
Open-market purchases and sales. 47 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 8SEC | Everett NevilleSee Remarks | Sell Plan | 6175,053 held (−11%) | $284.05 | $175K | -2.1% | — |
| Aug 20SEC | Nicole S. JonesSee Remarks | Sell Plan | 2,67725,880 held (−9%) | $279.61 | $749K | -0.6% | — |
| Aug 6SEC | Nicole S. JonesSee Remarks | Sell Plan | 19,43627,256 held (−42%) | $276.27 | $5.4M | +0.6% | — |
| Jun 16SEC | Jamie G. KatesChief Accounting Officer | Sell | 8992,368 held (−28%) | $298.61 | $268K | -6.9% | — |
| May 14SEC | David CordaniCEO, Chair | Sell Plan | 41,099163,082 held (−20%) | $290.00 | $11.9M | -4.1% | — |
| May 14SEC | David CordaniCEO, Chair | Sell Plan | 38,48788,545 held (−30%) | $294.98 | $11.4M | -5.8% | — |
| May 14SEC | David CordaniCEO, Chair | Sell Plan | 34,64153,904 held (−39%) | $295.98 | $10.3M | -6.1% | — |
| May 14SEC | David CordaniCEO, Chair | Sell Plan | 15,31936,568 held (−30%) | $298.24 | $4.6M | -6.8% | — |
| May 14SEC | David CordaniCEO, Chair | Sell Plan | 14,292218,020 held (−6%) | $287.96 | $4.1M | -3.5% | — |
| May 14SEC | David CordaniCEO, Chair | Sell Plan | 13,839204,181 held (−6%) | $288.85 | $4.0M | -3.8% | — |
| May 14SEC | David CordaniCEO, Chair | Sell Plan | 13,732149,350 held (−8%) | $291.01 | $4.0M | -4.5% | — |
| May 14SEC | David CordaniCEO, Chair | Sell Plan | 12,315137,035 held (−8%) | $291.95 | $3.6M | -4.8% | — |
| May 14SEC | David CordaniCEO, Chair | Sell Plan | 7,861129,174 held (−6%) | $292.88 | $2.3M | -5.1% | — |
| May 14SEC | David CordaniCEO, Chair | Sell Plan | 3,903232,312 held (−2%) | $286.83 | $1.1M | -3.1% | — |
| May 14SEC | David CordaniCEO, Chair | Sell Plan | 2,23134,337 held (−6%) | $298.53 | $666K | -6.9% | — |
| May 14SEC | David CordaniCEO, Chair | Sell Plan | 2,142127,032 held (−2%) | $293.92 | $630K | -5.4% | — |
| May 14SEC | David CordaniCEO, Chair | Sell Plan | 2,01751,887 held (−4%) | $296.84 | $599K | -6.3% | — |
| Mar 3SEC | Nicole S. JonesSee Remarks | Sell Plan | 2,30732,647 held (−7%) | $288.91 | $667K | -3.8% | — |
| Mar 3SEC | Everett NevilleSee Remarks | Sell Plan | 1,7195,670 held (−23%) | $288.91 | $497K | -3.8% | — |
| Nov 3SEC | David CordaniCEO, ChairFirst buy | Buy | 4,134157,935 held (+3%) | $241.88 | $1000K | +14.9% | — |
| Oct 7SEC | Brian C. EvankoSee Remarks | Sell Plan | 5,36851,182 held (−9%) | $300.00 | $1.6M | -7.3% | — |
Similar past setups: not applicable. CI has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with CI in the Research Lab
Pre-set to CI's latest insider buy of $10K or more (Nov 3, 2025: David Cordani, $1000K). Tap to change anything.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Cigna insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 4 sold $66.8M of CI stock on the open market; P/E 13.2 vs. a sector median of 25.0.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
CI insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $6.3M | 3 |
| Q2 2026 | — | 0 | $59.4M | 14 |
| Q1 2026 | — | 0 | $1.2M | 2 |
| Q4 2025 | $1000K | 1 | $1.6M | 1 |
Valuation, profit and volume
Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 0 Cigna insiders reported open-market purchases totaling $0, while 4 insiders reported sales totaling $66.8M. Among insiders with enough purchase history to measure, Eric J. Foss (Director) has the highest Insider Score at 66. 19 of 20 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
CI earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Nov 5, 2026 | -0.4% | None | -3.9%S&P -4.1% | pending |
| Jul 30, 2026 | -2.3% | None | -5.9%S&P +2.4% | -0.1% |
| Apr 30, 2026 | +7.2% | None | -3.2%S&P +1.3% | -1.9% |
| Feb 5, 2026 | +0.2% | None | +7.5%S&P +0.6% | -6.5% |
| Oct 30, 2025 | -1.0% | Sold $1.6M | -18.3%S&P -0.8% | +13.4% |
| Jul 31, 2025 | -1.5% | None | -12.0%S&P -2.0% | +14.7% |
| May 2, 2025 | +1.7% | None | -0.6%S&P +0.9% | -6.4% |
| Jan 30, 2025 | +6.4% | None | -3.0%S&P +0.0% | +5.0% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
CI short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded CI
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Alan ArmstrongSenate | Bought $1,001 - $15,000 | Mar 27, 2026 | Jul 21, 2026 | +7.3% |
What happened after CI insiders bought
Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.
| Filed | Insider | Bought | 7 days | 30 days | 90 days |
|---|---|---|---|---|---|
| Nov 3, 2025 | David CordaniCEO, Chair | $1000K | -0.2%+0.1% vs S&P | +4.5%+4.4% vs S&P | +5.6%+3.5% vs S&P |
Insiders at Cigna
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| David CordaniCEO, Chair | $1000K | $59.1M | May 14, 2026 | 1 of 1 | — |
| Nicole S. JonesSee Remarks | — | $6.8M | Aug 20, 2026 | — | — |
| Brian C. EvankoSee Remarks | — | $1.6M | Sep 3, 2026 | — | — |
| Everett NevilleSee Remarks | — | $672K | Sep 8, 2026 | — | — |
| Jamie G. KatesChief Accounting Officer | — | $268K | Jun 16, 2026 | — | — |
| Durga Prasad KokaEvp, Global Cio | — | — | Jun 3, 2026 | — | — |
| Eric C. WisemanDirector | — | — | Apr 24, 2026 | — | — |
| Philip OzuahDirector | — | — | Apr 24, 2026 | — | — |
| Michael J. HenniganDirector | — | — | Apr 24, 2026 | — | — |
| Kimberly A. RossDirector | — | — | Apr 24, 2026 | — | — |
| George KurianDirector | — | — | Apr 24, 2026 | — | — |
| Kathleen M. MazzarellaDirector | — | — | Apr 24, 2026 | — | — |
| Donna F. ZarconeDirector | — | — | Apr 24, 2026 | 0 of 1 | — |
| Neesha HathiDirector | — | — | Apr 24, 2026 | — | — |
| Mark B. McClellanDirector | — | — | Apr 24, 2026 | — | — |
| Eric J. FossDirector | — | — | Apr 24, 2026 | 0 of 1 | 66 |
| Ann M. DennisonCFO | — | — | Mar 3, 2026 | — | — |
Board links: companies that share insiders with CI
Directors and executives who filed Form 4s for CI and another company in the last 12 months.
- CDWCDW Donna F. Zarcone Director here · Director at CDW · latest filing Apr 24, 2026
- KKRKKR Kimberly A. Ross Director here · Director at KKR · latest filing Apr 24, 2026
- KYNKayne Anderson Energy Infrastructure Fund Michael J. Hennigan Director here · Director at KYN · latest filing Jun 24, 2026
- MPCMarathon Petroleum Michael J. Hennigan Director here · Chair at MPC · latest filing Apr 24, 2026
- NOCNorthrop Grumman Kimberly A. Ross Director here · Director at NOC · latest filing May 21, 2026
- NTAPNetApp George Kurian Director here · CEO at NTAP · latest filing Nov 17, 2026
- PRMBPrimo Brands Eric J. Foss Director here · CEO, Chair at PRMB · latest filing Aug 12, 2026
- SCHWCharles Schwab Neesha Hathi Director here · Md, Head Wealth Adv, Bnk, Tst at SCHW · latest filing Nov 3, 2026
- TNETTrinet Group Brian C. Evanko See Remarks here · Director at TNET · latest filing Sep 3, 2026
- WMWaste Management Kathleen M. Mazzarella Director here · Director at WM · latest filing May 18, 2026
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
CI stock: common questions
Are Cigna insiders buying CI stock?
No. No Cigna insider reported an open-market purchase of CI in the past 12 months. The latest was CEO, Chair David Cordani bought $1000K of CI at $241.88 — first open-market purchase in our records.
Are Cigna insiders selling CI stock?
4 insiders reported sales worth $66.8M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is CI's P/E ratio?
CI trades at about 13.2 times trailing earnings, compared with a median of 25.0 for the Health Care sector.
What is CI's 52-week range?
Over the past year CI has traded between $255.18 and $315.88. It last closed at $278.00 on Nov 20, 2026.